Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 3/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 2/20 | 0.37 |
| ▸ | KDM5A | P29375 | 1/20 | 0.37 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.37 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4437776 | 0.97 | ALDH1A1 (0.41) | APEX1ALDH1A1MAPK1KDM4EADORA1 | |
| SCHEMBL8847760 | 0.88 | ADORA1 (0.46) | APEX1ALDH1A1MAPK1KDM4EADORA1 | |
| SCHEMBL3707021 | 0.85 | CA12 (0.42) | ALDH1A1MAPK1KDM4EKMT2AHRH3 | |
| SCHEMBL1918976 | 0.85 | MAPT (0.40) | ALDH1A1MAPK1KDM4EKMT2AMEN1 | |
| SCHEMBL1918064 | 0.81 | F9 (0.36) | KDM4EADORA1KMT2ARECQL | |
| SCHEMBL5027701 | 0.80 | ADORA1 (0.35) | MAPK1KDM4EADORA1ADORA3ADORA2A | |
| SCHEMBL1919439 | 0.79 | ALDH1A1 (0.36) | ALDH1A1MAPK1RAB9A | |
| SCHEMBL13907870 | 0.79 | KMT2A (0.40) | ALDH1A1KDM4EADORA1ADORA3ADORA2A | |
| SCHEMBL13907803 | 0.79 | TDP1 (0.53) | ALDH1A1KDM4EKMT2AHRH3MEN1 | |
| SCHEMBL1917751 | 0.77 | ALDH1A1 (0.44) | ALDH1A1KDM4EKMT2ARECQLMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120040354-A | Telmisartan intermediate intermediate and preparation method thereof | 复星万邦(江苏)医药集团有限公司 | 2025-05-27 | — | — | CN | claimed |
| CN-117276497-A | Asphalt-based coated resin-based hard carbon composite material and preparation method and application thereof | 常州烯源谷新材料科技有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-114573513-B | Synthesis method of telmisartan intermediate | 济南大学 | 2023-05-16 | — | — | CN | claimed |
| CN-114573513-A | Synthesis method of telmisartan intermediate | 济南大学 | 2022-06-03 | — | — | CN | claimed |
| CN-112251770-B | Novel electrochemical preparation method of antihypertensive drug telmisartan intermediate | 湖南大学 | 2021-07-27 | — | — | CN | claimed |
| CN-112251770-A | Novel electrochemical preparation method of antihypertensive drug telmisartan intermediate | 湖南大学 | 2021-01-22 | — | — | CN | claimed |
| CN-109320461-B | Preparation method of telmisartan intermediate | 迪嘉药业集团有限公司 | 2020-02-07 | — | — | CN | claimed |
| CN-110698410-A | Preparation method of 2-n-propyl-4-methyl-6- (1' -methylbenzimidazole-2-yl) benzimidazole | 合肥立方制药股份有限公司 | 2020-01-17 | — | — | CN | claimed |
| CN-107118161-B | Synthesis method of 2-n-propyl-4-methylbenzimidazole-6-carboxylic acid | 湖北工业大学 | 2019-12-31 | — | — | CN | claimed |
| CN-109320461-A | A kind of preparation method of telmisartan intermediate | 威海迪素制药有限公司 | 2019-02-12 | — | — | CN | claimed |
| CN-102659686-B | Preparation method of 2-n-propyl-4-methyl-6-(1'-methylbenzimidazolyl-2-yl)benzimidazole | NINGBO CHEMGOO PHARMACEUTICAL TECHNOLOGY INNOVATION LTD | 2014-11-26 | — | — | CN | claimed |
| CN-103755641-A | Synthetic method for telmisartan intermediate | WEIHAI DIZHIYA PHARMACHEM DEV CO LTD | 2014-04-30 | — | — | CN | claimed |
| CN-102659686-A | Preparation method of 2-n-propyl-4-methyl-6-(1'-methylbenzimidazolyl-2-yl)benzimidazole | NINGBO CHEMGOO PHARMA TECH CO LTD | 2012-09-12 | — | — | CN | claimed |
| US-7943781-B2 | Process for preparing telmisartan | DR. REDDY'S LABORATORIES LIMITED (IN) | 2011-05-17 | — | — | US | claimed |
| WO-2010081670-A2 | PROCESS FOR THE PREPARATION OF BENZIMIDAZOLES | LONZA LTD (CH) | 2010-07-22 | — | — | WO | claimed |
| CN-101172968-B | 2-propyl-4 methyl-6-(tolimidazole-2group) benzoglioxaline salt and method for producing the same | ZHEJIANG TIANYU PHARMACEUTICAL CO LTD | 2010-05-12 | — | — | CN | claimed |
| EP-1805146-A4 | PROCESS FOR PREPARING TELMISARTAN | REDDYS LAB LTD DR (IN) | 2009-01-14 | — | — | EP | claimed |
| US-20070287840-A1 | Process for Preparing Telmisartan | DR. REDDY'S LABORATORIES LIMITED (IN) | 2007-12-13 | — | — | US | claimed |
| EP-1805146-A2 | PROCESS FOR PREPARING TELMISARTAN | Dr. Reddy's Laboratories Ltd. (IN) | 2007-07-11 | — | — | EP | claimed |
| WO-2006044754-A2 | PROCESS FOR PREPARING TELMISARTAN | DR. REDDY'S LABORATORIES LTD. (IN) | 2006-04-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287840-A1 | Process for Preparing Telmisartan | AGT, TTR, REN | APEX1 1851/4885ALDH1A1 2741/4885MAPK1 1129/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.